207 related articles for article (PubMed ID: 27809504)
1. Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
Granchi C; Rizzolio F; Palazzolo S; Carmignani S; Macchia M; Saccomanni G; Manera C; Martinelli A; Minutolo F; Tuccinardi T
J Med Chem; 2016 Nov; 59(22):10299-10314. PubMed ID: 27809504
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a new reversible MAGL inhibitor.
Tuccinardi T; Granchi C; Rizzolio F; Caligiuri I; Battistello V; Toffoli G; Minutolo F; Macchia M; Martinelli A
Bioorg Med Chem; 2014 Jul; 22(13):3285-91. PubMed ID: 24853323
[TBL] [Abstract][Full Text] [Related]
3. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
[TBL] [Abstract][Full Text] [Related]
4. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
[TBL] [Abstract][Full Text] [Related]
5. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
[TBL] [Abstract][Full Text] [Related]
6. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.
Bononi G; Tonarini G; Poli G; Barravecchia I; Caligiuri I; Macchia M; Rizzolio F; Demontis GC; Minutolo F; Granchi C; Tuccinardi T
Eur J Med Chem; 2021 Nov; 223():113679. PubMed ID: 34218085
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
[TBL] [Abstract][Full Text] [Related]
8. Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
Poli G; Lapillo M; Jha V; Mouawad N; Caligiuri I; Macchia M; Minutolo F; Rizzolio F; Tuccinardi T; Granchi C
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):589-596. PubMed ID: 30696302
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors.
Zhi Z; Zhang W; Yao J; Shang Y; Hao Q; Liu Z; Ren Y; Li J; Zhang G; Wang J
J Med Chem; 2020 Jun; 63(11):5783-5796. PubMed ID: 32429662
[TBL] [Abstract][Full Text] [Related]
10. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Ruggiero E; De Stefano L; Rizzolio F; Di Cesare Mannelli L; Ghelardini C; Chicca A; Lapillo M; Gertsch J; Manera C; Macchia M; Martinelli A; Granchi C; Minutolo F; Tuccinardi T
J Med Chem; 2018 Feb; 61(3):1340-1354. PubMed ID: 29309142
[TBL] [Abstract][Full Text] [Related]
12. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.
Granchi C; Caligiuri I; Bertelli E; Poli G; Rizzolio F; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1240-1252. PubMed ID: 28936880
[TBL] [Abstract][Full Text] [Related]
13. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
[TBL] [Abstract][Full Text] [Related]
14. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
[TBL] [Abstract][Full Text] [Related]
15. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
[TBL] [Abstract][Full Text] [Related]
17. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.
Butler CR; Beck EM; Harris A; Huang Z; McAllister LA; Am Ende CW; Fennell K; Foley TL; Fonseca K; Hawrylik SJ; Johnson DS; Knafels JD; Mente S; Noell GS; Pandit J; Phillips TB; Piro JR; Rogers BN; Samad TA; Wang J; Wan S; Brodney MA
J Med Chem; 2017 Dec; 60(23):9860-9873. PubMed ID: 29148769
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.
Lauria S; Perrotta C; Casati S; Di Renzo I; Ottria R; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
Bioorg Med Chem; 2018 May; 26(9):2561-2572. PubMed ID: 29678535
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
Jaiswal S; Ayyannan SR
ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
